Abortion

This analysis uses the 2019 IBM MarketScan claims data to look at prescriptions of methotrexate and misoprostol, two drugs that can be used to terminate pregnancies, but are also used to manage chronic conditions like cancer, autoimmune diseases, and abnormal bleeding. These drugs may be restricted in response to state abortion bans, which we find will disproportionately affect women of reproductive age who make up the majority of those who rely on these drugs.

Few Voters Know About the Medicare Drug Provisions in the Inflation Reduction Act, Though Seniors are More Aware and Would Be Likely to Vote for Candidates Who Support Them About a month ahead of the 2022 midterm election, abortion continues to grow as a motivating issue for voters, especially among…

Leading up to the November 2022 midterm elections, abortion access is motivating majorities of Democratic women, women under 50 and and Democratic voters in states with abortion bans. For older voters, some health care issues related to Medicare costs are resonating.

Four states (CA, MI, VT, and KY) will vote on ballot measures related to abortion rights in the November 2022 elections. This policy watch summarizes each of these ballot measures and their implications.

More than six months since the Supreme Court issued their Dobbs decision which overturned Roe v. Wade, there is widespread public confusion about the medication abortion pill and whether it is legal at the state level, according to the latest KFF Health Tracking Poll. The poll also finds many are…

Following the FDA approval of retail pharmacies carrying and distributing medication abortion, this poll finds that the public’s awareness and knowledge of emergency contraception and medication abortion is still lacking, especially among respondents living in states with full abortion bans.

As the nation marks the 50th anniversary of the Supreme Court of the United States landmark Roe v. Wade decision, which the Supreme Court overturned, 14 states have active litigation challenging state abortion bans and restrictions. A new KFF brief explains how individuals and organizations suing to block the bans…

This issue brief presents an overview of the legal challenges presented in state courts since the Dobbs ruling in June 2022 and highlights some of the novel strategies that are being used to defend access to abortion in states that have enacted abortion bans.

This survey looks at the public’s health care priorities for the new Congress, including price transparency, mental health, abortion, Medicaid, and health costs. It also looks at the public’s views of the main health provisions in the Inflation Reduction Act (IRA), including on Medicare drug prices.

The Supreme Court’s decision to overturn Roe v. Wade and subsequent state abortion bans have moved the issue of access to high-quality and affordable contraceptive care to the forefront. As these seismic shifts shape women’s health care in the United States, the FDA is considering an application for a daily…